|Combination antiretroviral therapy and the risk of myocardial infarction|
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
|Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis|
A Telenti, P Imboden, F Marchesi, L Matter, K Schopfer, T Bodmer, ...
The Lancet 341 (8846), 647-651, 1993
|Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis|
A Telenti, F Marchesi, M Balz, F Bally, EC Böttger, T Bodmer
Journal of clinical microbiology 31 (2), 175-178, 1993
|Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study|
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
|Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study|
A Rauch, Z Kutalik, P Descombes, T Cai, J Di Iulio, T Mueller, M Bochud, ...
Gastroenterology 138 (4), 1338-1345. e7, 2010
|A whole-genome association study of major determinants for host control of HIV-1|
J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ...
science 317 (5840), 944-947, 2007
|Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody|
D Pinto, YJ Park, M Beltramello, AC Walls, MA Tortorici, S Bianchi, ...
Nature 583 (7815), 290-295, 2020
|Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study|
G Greub, B Ledergerber, M Battegay, P Grob, L Perrin, H Furrer, ...
The Lancet 356 (9244), 1800-1805, 2000
|Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel|
MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ...
Jama 304 (3), 321-333, 2010
|Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel|
MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson, P Cahn, JJ Eron, ...
Jama 308 (4), 387-402, 2012
|Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study|
B Ledergerber, M Egger, M Opravil, A Telenti, B Hirschel, M Battegay, ...
The Lancet 353 (9156), 863-868, 1999
|Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration|
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
|Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients|
C Marzolini, A Telenti, LA Decosterd, G Greub, J Biollaz, T Buclin
Aids 15 (1), 71-75, 2001
|The major genetic determinants of HIV-1 control affect HLA class I peptide presentation|
Science 330 (6010), 1551-1517, 2010
|Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1|
MP Martin, Y Qi, X Gao, E Yamada, JN Martin, F Pereyra, S Colombo, ...
Nature genetics 39 (6), 733-740, 2007
|Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study|
J Fellay, C Marzolini, ER Meaden, DJ Back, T Buclin, JP Chave, ...
The Lancet 359 (9300), 30-36, 2002
|Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors|
D Périard, A Telenti, P Sudre, JJ Cheseaux, P Halfon, MJ Reymond, ...
Circulation 100 (7), 700-705, 1999
|Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses|
S Paust, HS Gill, BZ Wang, MP Flynn, EA Moseman, B Senman, ...
Nature immunology 11 (12), 1127-1135, 2010
|Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations|
HE Takiff, L Salazar, C Guerrero, W Philipp, WM Huang, B Kreiswirth, ...
Antimicrobial agents and chemotherapy 38 (4), 773-780, 1994
|The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol|
A Telenti, WJ Philipp, S Sreevatsan, C Bernasconi, KE Stockbauer, ...
Nature medicine 3 (5), 567-570, 1997